Literature DB >> 16414384

Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients.

Christopher D Leville1, Vikram S Kashyap, Daniel G Clair, James F Bena, Sean P Lyden, Roy K Greenberg, Patrick J O'Hara, Timur P Sarac, Kenneth Ouriel.   

Abstract

OBJECTIVE: The preferential use of endovascular techniques to treat complex aortoiliac disease has increased in recent years. The purpose of this study was to review the outcomes and durability of recanalization, percutaneous transluminal angioplasty, and stenting for iliac occlusions based on the patient's TransAtlantic Inter-Society Consensus (TASC) stratification.
METHODS: Between 1998 and 2004, more than 628 patients with a clinical diagnosis of aortoiliac atherosclerotic disease underwent arteriography. The endovascular treatment of 89 consecutive patients (mean age, 66 years; 58% male) with symptomatic iliac occlusions (TASC-B, -C, and -D) was the basis for this study. Original angiographic imaging was evaluated for lesion grade and runoff. Electronic and hard copy medical records were reviewed for demographic data, clinical variables, and noninvasive vascular laboratory testing. Kaplan-Meier estimators were used to determine patency rates according to Society for Vascular Surgery criteria. Univariate and multivariate analyses were performed. P values of <.05 were considered significant.
RESULTS: Recanalization and percutaneous transluminal angioplasty/stenting (total, 178 stents) of occluded iliac arteries was technically successful in 84 (91%) of 92 procedures. Patients in the TASC-C and -D groups often required multiple access sites (50%) and femoral artery endarterectomy/patch angioplasty for diffuse disease (24%). The mean ankle-brachial index increased from 0.45 to 0.83. Distal embolization led to major amputation and eventual death in one patient. Two other deaths occurred in the perioperative period secondary to cardiorespiratory causes. Three-year primary patency, secondary patency, and limb salvage rates were 76%, 90%, and 97%, respectively, and progression of infrainguinal disease led to late limb loss in two patients. Diabetes as a risk factor was significantly associated with decreased primary patency (57% vs 83%; P = .049). Critical ischemia at presentation was associated with decreased patency rates as well (P = .002), but TASC classification did not significantly alter patency rates.
CONCLUSIONS: Complex long-segment and bilateral iliac occlusions can be safely treated via endovascular means with high rates of symptom resolution. Initial technical success, low morbidity, and mid-term durability are comparable to results with open reconstruction. A liberal posture to open femoral artery reconstruction extends the ability to treat diffuse TASC-C and -D lesions via endovascular means.

Entities:  

Mesh:

Year:  2006        PMID: 16414384     DOI: 10.1016/j.jvs.2005.09.034

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  36 in total

1.  An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.).

Authors:  Michael R Jaff; Christopher J White; William R Hiatt; Gerry R Fowkes; John Dormandy; Mahmood Razavi; Jim Reekers; Lars Norgren
Journal:  Ann Vasc Dis       Date:  2015-10-23

Review 2.  Current state of diagnosis and management of critical limb ischemia.

Authors:  Dan Clair; Samir Shah; John Weber
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 3.  Strategies for managing aortoiliac occlusions: access, treatment and outcomes.

Authors:  Daniel G Clair; Jocelyn M Beach
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-05

4.  Robot-assisted laparoscopic aortobifemoral bypass: initial experience developing a new program.

Authors:  H Edward Garrett; Joss D Fernandez; Charlotte Porter
Journal:  J Robot Surg       Date:  2008-11-22

5.  Endovascular management of aortoiliac occlusive disease.

Authors:  Melissa J Neisen
Journal:  Semin Intervent Radiol       Date:  2009-12       Impact factor: 1.513

6.  Multisystem revascularization.

Authors:  Zehra Jaffery; Arthur Grant
Journal:  Ochsner J       Date:  2009

7.  Endovascular Management of Flush Common Iliac Artery Occlusive Disease: Challenges and Solutions.

Authors:  Baker Ghoneim; Walied Eldaly; Hussein Elwan; Ahmed Taha
Journal:  Int J Angiol       Date:  2016-07-25

Review 8.  Peripheral artery disease. Part 2: medical and endovascular treatment.

Authors:  Mitchell D Weinberg; Joe F Lau; Kenneth Rosenfield; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

9.  Successful hybrid treatment with endovascular aorto-iliac revascularization and coronary bypass surgery in a patient with an advanced complex polyvascular disease.

Authors:  Yukako Ogoyama; Nobuhiko Ogata; Shinichi Toriumi; Kazuomi Kario
Journal:  J Cardiol Cases       Date:  2017-04-10

10.  Mid-term outcomes following endovascular re-intervention for iliac artery in-stent restenosis.

Authors:  Usman Javed; Christopher R Balwanz; Ehrin J Armstrong; Khung-Keong Yeo; Gagan D Singh; Satinder Singh; David Anderson; Gregory G Westin; William C Pevec; John R Laird
Journal:  Catheter Cardiovasc Interv       Date:  2013-05-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.